The acquisition adds to the comprehensive biotechnology services that AIBioTech currently provides to its clients by performing assessments that examine the effects of drugs, chemicals, biologics, and other
A new distribution center in Singapore and the recent expansion of the company’s facilities in Billerica, Mass., will help PAREXEL more effectively manage clients’ global clinical trial supply
The collaboration enables each party to promote innovative new medicine research and development. This is the first time that a compound library partnership of this scale has been
The allowed patent is a formulation patent and covers the DETERx technology platform. As such, the claims cover multiple products in Collegium’s development pipeline. This is the sixth
IBM and NYGC will test a unique Watson prototype designed specifically for genomic research as a tool to help oncologists deliver more personalized care to cancer patients. NYGC
HS-110 is Heat’s first product candidate in a series of its proprietary Immune Pan Antigen Cytotoxic Therapy ("ImPACT") based allogeneic cell lines designed to direct killer T cells
The prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center clinical trial enrolled 230 adult and pediatric patients as young as five years of age, across 31 US sites. For the
Pharma Two B is following the US Food and Drug Administration’s (FDA) 505(b)(2) registration pathway for P2B001. The study titled A Phase 2B, 12-week multi-center, randomized, double-blind, placebo-controlled,
Each company will bring its specific expertise to the joint venture; GrowLife providing equipment manufacturing while Vape Holdings provides guidance for the process technology and concentrate formulas. Cannabis
The trial is being conducted at UC San Diego Moores Cancer Center. This Phase II G-202 trial will treat up to 34 patients with GBM that has progressed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.